Targeted Disruption of the Stat1 Gene in Mice Reveals Unexpected Physiologic Specificity in the JAK–STAT Signaling Pathway  by Meraz, Marco A et al.
Cell, Vol. 84, 431±442, February 9, 1996, Copyright 1996 by Cell Press
Targeted Disruption of the Stat1 Gene in Mice
Reveals Unexpected Physiologic Specificity
in the JAK±STAT Signaling Pathway
Marco A. Meraz,*² J. Michael White,* the identification of a novel intracellular signaling path-
way termed the JAK±STAT pathway (Darnell et al., 1994;Kathleen C. F. Sheehan,* Erika A. Bach,*
Ihle et al., 1994; Schindler and Darnell, 1995). This path-Scott J. Rodig,* Anand S. Dighe,* Daniel H. Kaplan,*
way utilizes two groups of essential elements in additionJoan K. Riley,* Andrew C. Greenlund,*
to the cytokine receptor polypeptides. The first is aDayle Campbell,* Karen Carver-Moore,³
group of janus family tyrosine kinases containing theRaymond N. DuBois,§ Ross Clark,³ Michel Aguet,‖#
members JAK1, JAK2, JAK3, and TYK2. Individual familyand Robert D. Schreiber*
members preferentially and constitutively associate with*Center for Immunology
the intracellular domainsof particularcytokine receptorsDepartment of Pathology
and become activated following ligand-induced assem-Washington University School of Medicine
bly of receptor subunits at the cell surface. The secondSt. Louis, Missouri 63110
is a family of src homology 2 (SH2) domain±containing,‖ Institute of Molecular Biology I
latent cytosolic transcription factors known as signalUniversity of ZuÈ rich
transducers and activators of transcription (STATs),HoÈ nggerberg
which currently consists of the proteins STAT1 through8093 ZuÈ rich
STAT6. Ligation of a specific cytokine receptor leads toSwitzerland
the recruitment and activation of a distinct pattern of§Departments of Medicine and Cell Biology
STAT proteins, which become activated by tyrosineVanderbilt University Medical Center
phosphorylation, form homodimers and heterodimers,Nashville, Tennessee 37232
translocate to the nucleus, and promote the transcrip-³Department of Molecular Biology
tional activation of cytokine-inducible genes.Genentech, Incorporated
The rapid elucidation of the JAK±STAT pathway hasSouth San Francisco, California 92080
been made possible in part through the detailed investi-
gation of interferon signaling. The STAT protein family
was initially discovered based on the observation that
Summary
two family members, STAT1 and STAT2, were activated
by interferon-a (IFNa) (Fu et al., 1992; Schindler et al.,
The JAK±STAT signaling pathway has been implicated 1992), while only STAT1 was activated by IFNg (Schind-
in mediating biologic responses induced by many cy- ler et al., 1992; Shuai et al., 1992). In addition, the discov-
tokines. However, cytokines that promote distinct cel- ery of a physiologic role for the janus family of tyrosine
lular responses often activate identical STAT proteins, kinases was established by the demonstration that mu-
thereby raising the question of how specificity is mani- tagenized cells lacking TYK2 (Velazquez et al., 1992) or
fest within this signaling pathway. Here we report the JAK1 (MuÈ ller et al., 1993) were unable to respond to
generation and characterization of mice deficient in IFNa and that mutant cells lacking either JAK1 or JAK2
STAT1. STAT1-deficient mice show no overt develop- were IFNg unresponsive (MuÈ ller et al., 1993; Watling et
mental abnormalities, but display a complete lack of al., 1993). These important findings stimulated subse-
responsiveness to either IFNa or IFNg and are highly quent studies that identified several other members of
sensitive to infection by microbial pathogens and vi- the JAK and STAT families and defined their interactions
ruses. In contrast, these mice respond normally to with other cytokine receptors.
several other cytokines that activate STAT1 in vitro. The analysis of IFN signaling has continued to provide
These observations document that STAT1 plays an insights into the JAK±STAT pathway by elucidating one
obligate and dedicated role in mediating IFN-depen- mechanism by which pathway specificity is manifest.
dent biologic responses and reveal an unexpected Recent work has shown that ligation of the IFNg receptor
level of physiologic specificity for STAT1 action. leads to the rapid phosphorylation of a particular tyro-
sine-containing sequence near the carboxyl terminus of
Introduction the receptor a chain, thereby forming a specific docking
site on the receptor for STAT1 (Greenlund et al., 1994,
Cytokines exert their pleiotropic effects on cells by inter- 1995). Binding of STAT1 to the ligand-induced receptor
acting with specific receptors expressed at the cell sur- docking site is specific, of moderately high affinity (137
face. In general, cytokine receptors do not express en- nM), mediated by the STAT1 SH2 domain, and required
dogenous kinase or phosphatase activities, yet many for subsequent STAT1 activation. This observation has
become rapidly and reversibly tyrosine phosphorylated formed the basis of the hypothesis that the unique pat-
following ligation in intactcells. The biologic significance tern of STAT proteins activated by each cytokine is de-
of this observation has recently beenmade clear through termined by the ability of each STAT protein to bind
to specific docking sites generated in the intracellular
domains of the different cytokine receptors following²Present address: Department BiologiaCelular, Centro de Investiga-
ligation. This hypothesis has been supported by addi-cion y de Estudios Avanzados del Instituto Politecnico Nacional,
tional studies conducted on a variety of cytokine recep-Mexico City, Mexico.
tors, including those for interleukin-4 (IL-4) (Hou et al.,#Present address: Department of Molecular Biology, Genentech,
Incorporated, South San Francisco, California 92080. 1994; Schindler et al., 1995), IFNa (Leung et al., 1995;
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Figure 1. Targeted Disruption of the Murine
Stat1 Gene
A schematic representation of 18 kb of the
murine Stat1 gene is shown at the top. The
numbered closed boxes (I±IV) denote the four
59 translated exons of the gene. The double-
headed arrow indicates the endogenous 8.5
kb BamHI fragment characteristic of the wild-
type gene as defined using a labeled DNA
fragment derived from the 59 end of the Stat1
locus not included in the targeting vector
(probe A). XbaI (X), BamHI (B), and SauI (S)
sites are indicated. The N and S3A labels rep-
resent NotI and Sau3A sites, respectively,
that are contributed by the phage arms. The
targeting vector schematic shows the posi-
tion of the neomycin resistance gene (neo)
and the thymidine kinase gene (TK), oriented
as indicated by the arrows. The vector was
designed such that the phosphoglycerate ki-
nase±neo cassette replaced the first three
translated exons of the Stat1 gene together
with 0.7 kb of 59 upstream sequence. The
targeting vector was electroporated into the
GS-1 embryonic stem (ES) cell line, and
transfectants were positively and negatively
selected using G418 and FIAU, respectively.
DNA from resistant clones was screened by
Southern blot analysis following BamHI di-
gestion and probed with a 32P-labeled 0.7 kb
probe derived from a region of the gene that
was 0.9 kb upstream from the targeted sites
(probe A). On the basisof thisscreening strat-
egy, the wild-type allele produced an 8.5 kb
BamHI digestion product, while the disrupted
allele gave rise to a 5.5 kb hybridizing product
(bottom).
Heim et al., 1995), IL-6 (Stahl et al., 1995), IL-2 (Hou mice display a globalstate of unresponsiveness toeither
IFNa or IFNg and are unable to resolve infections byet al., 1995), and IL-10 (R. Weber-Nordt and R. D. S.,
unpublished data), and now is considered a general microbial pathogens and viruses. However, these mice
display no developmental abnormalities and maintainparadigm that explains one element of JAK±STAT path-
way signaling specificity. normal responsiveness to several other cytokines that
activate STAT1 in vitro. Thus, this study not only demon-However, two additional important questions con-
cerning the specificity of the JAK±STAT pathway remain strates the obligate role played by STAT1 in effecting
cellular responses to the interferons, but also revealsunanswered, and both may be addressed in the context
of IFN signaling. The first is whether this pathway partici- an unexpected level of specificity within the JAK±STAT
pates in the induction of all IFN-dependent biologic re- pathway when activated under physiologic conditions.
sponses or whetheralternative signalingpathways exist.
The second is whether STAT1 is required by other cyto-
Resultskines in order to effect cellular responses. This latter
question is particularly important since many cytokines
Generation of STAT1-Deficient Micethat induce biologic responses in cells that are distinct
A Stat1-targeting construct was designed to replace thefrom those induced by the interferons have been shown
first three translated exons of the Stat1 gene and 0.7to activate STAT1-dependent DNA binding activity in
kb of 59 upstream sequence with a neomycin resistancevitro. These include IL-6 (Larner et al., 1993), IL-10 (Fin-
cassette and to insert the herpes simplex virus thymi-bloom and Winestock, 1995; R. Weber-Nordt and
dine kinase gene 8.0 kb downstream for negative selec-R. D. S., unpublished data), macrophage colony-stimu-
tion against nonhomologous recombination events (Fig-lating factor 1 (CSF1) (Larner et al., 1993), epidermal
ure 1). Successful targeting of the Stat1 gene wasgrowth factor (EGF) (Fu and Zhang, 1993), platelet-de-
achieved in three out of 96 transfected clones. The threerived growth factor (PDGF) (Wen et al., 1995), angioten-
independent targetedembryonic stem clones were usedsin (Bhat et al., 1994), growth hormone (GH) (Gronowski
to produce male chimeras that were able to effect germ-et al., 1995), and thrombopoietin (Gurney et al., 1995).
line transmission of the disrupted allele when bred toTo address these questions, we generated mice that
either C57BL/6 or 129/Sv females. Heterozygote by het-lack functionally active STAT1 using homologous re-
erozygote breedings produced offspring that segre-combination techniques and characterized their ability
gated in a Mendelian distribution into groups that con-to respond to IFNa and IFNg as well as other cytokines.
The analyses reported here reveal that STAT1-deficient tained the wild-type Stat1 gene (95 offspring) or were
Selective IFN Unresponsiveness in STAT1-Deficient Mice
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heterozygous (225 offspring) or homozygous (91 off-
spring) for the disrupted Stat1 allele, as detected by
Southern blot analysis (Figure 1).
Homozygous Stat1 gene±targeted mice did not show
any overt developmental abnormalities. All tissues and
organs were found to be intact and organized in an
appropriate manner. The mice were indistinguishable
from theirnormal counterparts on the basis of size, activ-
ity, or ability to reproduce. Immunostaining and fluores-
cence-activated cell sorter (FACS) analysis of thymus
and spleen revealed the presence of the expected popu-
lations and subpopulations of T cells, B cells, and mac-
rophages (data not shown). However, even though the
mice were housed in a specific pathogen±free facility,
we noted that a small proportion of Stat1 gene±targeted
mice (but not their wild-type or heterozygote littermates)
sometimes died with enlarged spleens and livers that
contained small white foci of undetermined origins. This
latter result suggested that Stat1 gene±targeted mice
were more susceptible to opportunistic infections than
their STAT1-sufficient counterparts.
Stat1 Gene±Targeted Mice Produce a Limited
Amount of an Abnormal STAT1 Protein
That Is Functionally Inactive
Different tissues and organs from wild-type and gene-
targeted mice were analyzed for expression of STAT1
protein. For these experiments, STAT1 was immunopre-
cipitated from tissue homogenates using an antibody
specific for the carboxyl terminus of the protein and
then analyzed by Western blotting using antibodies spe- Figure 2. Stat1 Gene±Targeted Mice Produce a Limited Amount of
cific for the STAT1 SH2 domain. All tissues derived from an Abnormal STAT1 Protein
wild-type mice expressed theappropriate 91 kDa STAT1 (A) Stat1 gene±targeted mice produce limited quantities of an abnor-
protein (Figure 2A). In contrast, tissues derived from the mal STAT1-related protein. Tissues and organs from wild-type (WT,
lanes a, c, e, and g) and gene-targeted mice (Def, lanes b, d, f, andStat1 gene±targeted mice expressed a low level of a
h) were homogenized and/or solubilized in lysis buffer, as describedprotein that cross-reacted with the STAT1-specific anti-
in Experimental Procedures, and STAT1 was immunoprecipitatedbodies but displayed an Mr of 72 kDa. Densitometric using the SC-111 MAb specific for the carboxyl terminus of the
analysis revealed that the STAT1-related protein was protein. Precipitates were analyzed by Western blotting using the
present at 4%±7% the level of native STAT1 expressed ATO-1D6 MAb specific for the STAT1 SH2 domain. Blots were devel-
in wild-type cells. Similar values were obtained when oped using the enhanced chemiluminescence system and quanti-
tated by densitometry, as outlined in Experimental Procedures.different combinations of STAT1-specific antibodies
(B) The abnormal protein produced by gene-targeted mice lackswere used in the analysis.
the STAT1 amino terminus. STAT1 was immunoprecipitated fromTo define the relationship between wild-type STAT1
the thymus of wild-type or gene-targeted mice as in (A), and thenand the STAT1-related protein observed in the gene-
Western blotting was performed using antibodies specific for the
targeted mice, we immunoprecipitated the proteins out STAT1 amino terminus (N-Term), SH2 domain (SH2), and carboxyl
of thymic tissue extracts and then analyzed them by terminus (C-Term).
(C) Stat1 gene±targeted mice express low levels of an abnormalWestern blotting using STAT1 antibodies specific for
Stat1 transcript. Poly(A)1 RNA derived from 40 mg of total RNAthe amino terminus, SH2 domain, or carboxyl terminus
isolated from the liver of either wild-type (WT) or gene-targetedof the protein (Figure 2B). Whereas all three antibodies
(Stat1 Def) mice was subjected to Northern blot analysis using la-
detected STAT1 precipitated from the thymus of wild- beled probes that represented the full-length cDNAs for murine
type mice, only the SH2 domain±specific and carboxyl STAT1 (top) or human b actin (bottom).
terminus±specific antibodies recognized the STAT1- (D) Abnormal STAT1 can be activated to express minimal amounts
of DNA binding activity following IFNg treatment of cells. We incu-related protein derived from the gene-targeted mice.
bated 5 3 106 bone marrow macrophages derived from wild-typeStat1 transcripts from gene-targeted mice were also
or Stat1 gene±targeted mice for 7 min at 378C with either PBS orsmaller in size and present in amounts that were only
10,000 IRU/ml of murine IFNg and quantitated DNA binding activity
4% those found in wild-type cells (Figure 2C). When by EMSA employing a 32P-labeled 18 bp probe derived from the
treated with IFNg, cells from the Stat1 gene±targeted IFNg response region of the human FcgRI gene.
mice produced only minimal (<2%) amounts of a moiety
capable of binding to an IFNg-responsive DNA element
(GAS site) compared with cells from wild-type mice as with STAT1-specific antisera (data not shown). Based
on our targeting strategy, the known sequence of murineassessed using an electrophoretic mobility shift assay
(EMSA) (Figure 2D). This moiety could be supershifted STAT1, the molecular mass displayed by the abnormal
Cell
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protein, and the recent suggestion that the Stat1 gene
may contain an untranslated exon located approxi-
mately 3 kb upstream of the translation initiation site
(Yan et al., 1995), we conclude that the abnormal STAT1-
related protein expressed in the gene-targeted mice
most likely represents a STAT1 mutant that initiates at
the internal methionine residue at position 135.
The extremely low level of activated STAT1 dimers
formed in IFNg-treated cells from gene-targeted mice
suggested that, even if the abnormal protein were fully
functional, its low expression level would severely ham-
per its ability to promote biologic responses. However,
to test the functional potential of the abnormal STAT1
protein, polyoma virus large T antigen immortalized
mouse kidney fibroblasts (MKFs) were transiently
transfected with expression plasmids encoding either
wild-type STAT1 or the abnormal STAT1 lacking the
amino-terminal 134 amino acids. The ability of the
transfected cells to respond to murine IFNg was then
assessed by monitoring enhancement of major histo-
compatability complex (MHC) class I proteins at the cell
surface. As expected, IFNg induced high level expres-
sion of MHC class I proteins on wild-type MKFs (which
expressed the native 91 kDa STAT1 protein). In contrast,
IFNg failed to enhance MHC class I expression on MKFs
derived from the gene-targeted mice (which expressed
the abnormal 72 kDa protein) (Figure 3A). Transient
transfection of MKFs from gene-targeted mice with an
expression vector encoding wild-type STAT1 led to cel-
lular expression of the wild-type 91 kDa protein (Figure
3A, bottom) and reconstituted cellular responsiveness
to IFNg in 27% of the population (Figure 3A, top). In
contrast, expression of the abnormal STAT1 protein in
these cells did not reconstitute cellular responsiveness
to IFNg (Figure 3A, top), even though the transfected
cells expressed the abnormal 72 kDa protein at levels
that were comparable with those exhibited by wild-type
STAT1 expressed in gene-targeted MKFs or natural
STAT1expressed inwild-type MKFs (Figure 3A, bottom).
Similar results were obtained when wild-type and ab-
normal STAT1 proteins were stably expressed in the
U3A mutant human cell line that is deficient in STAT1
(Figure 3B).
Thus, taken together these results demonstrate that
the Stat1 gene±targeted mice produce minimal quanti-
ties of an abnormal STAT1 protein that is functionally
inactive. Based on these results, the mice will hereafter
be referred to as STAT1-deficient mice.
experiments, STAT1 was immunoprecipitated using the ATO-1D6
STAT1 SH2 domain±specific MAb and detected using biotinylated
Figure 3. The Abnormal STAT1 Produced in Stat1 Gene±Targeted ATO-2F5 STAT1 specific±MAb. To improve visualization of the ab-
Mice Is Unable to Support IFN-Mediated Biologic Responses normal protein in MKFs derived from gene-targeted mice, we used
three times as many gene-targeted MKFs in lane 2 compared with(A) Abnormal STAT1 cannot reconstitute IFNg signaling in transiently
transfected cells derived from STAT1-deficient mice. Immortalized the other lanes.
(B) Abnormal STAT1 cannot reconstitute IFNg signaling in stablyMKFs derived from STAT1-deficient mice were transiently
transfected with empty vector or with expression plasmids that transfected human STAT1-deficient cells. The human STAT1-defi-
cient U3A cell line was stably transfected with either empty vector orencoded either wild-type murine STAT1 or the abnormal STAT1
protein. Cells were treated with murine IFNg (1000 IRU/ml) for 48 hr expression plasmids encoding wild-type orabnormal murine STAT1.
After selection, cell populations were cloned and tested for IFNgand then analyzed for expression of MHC class I proteins by flow
cytometry (top). Cells were also subjected to Western blot analysis responsiveness (top) and STAT1 protein expression (bottom) as
described above. At least two representative clones were tested.for STAT1 protein expression 24 hr after transfection. For these
Selective IFN Unresponsiveness in STAT1-Deficient Mice
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IFNg or by varying the time of stimulation (data not
shown). To test whether a similar state of unrespon-
siveness could also be observed in vivo, we intraperito-
neally injected wild-type and STAT1-deficient mice with
phosphate-buffered saline (PBS) or 20 mg of either IFNa
or IFNg and then quantitated steady-state IRF1 mRNA
levels in the livers of the treated mice 4 hr later. Whereas
IFNa and IFNg induced IRF1 gene transcription in livers
of normal mice, neither IFNinduced IRF1 gene activation
in the livers of STAT1-deficient mice (data not shown).
Similar results were obtained for induction of the
genes for guanylate-binding protein 1 (GBP1), the MHC
class II transactivating protein (CIITA), the complement
protein C3 (Figure 4), and the complement protein factor
B (data not shown) in bone marrow macrophages stimu-
lated in vitro. For all four of these genes, IFNa or IFNg
induced maximal levels of mRNA in wild-type cells at 6
hr, but failed to induce transcripts in cells derived from
STAT1-deficient mice. Thus, neither IFNa nor IFNg was
able to activate IFN-inducible genes in cells derived from
STAT1-deficient mice either in vitro or in vivo.
Lack of IFNa- and IFNg-Induced Expression
of Immunoregulatory Proteins in Cells
Derived from STAT1-Deficient Mice
We next compared the ability of IFNa and IFNg to induce
expression of three important immunoregulatory pro-
teins on the surface of leukocytes derived from wild-
type or STAT1-deficient mice. Peripheral blood T cells
from either normal or STAT1-deficient mice expressed
Figure 4. Lack of Gene Expression in IFN-Treated Macrophages comparable basal levels of MHC class I proteins (Figure
from STAT1-Deficient Mice 5, top). However, when exposed to either IFNa or IFNg
Northern blot analysis of RNA derived from bone marrow macro- for 72hr, wild-type T cells up-regulated cell surface MHC
phages produced from wild-type or STAT1-deficient mice. Macro-
class I expression, while T cells derived from STAT1-phages were treated with PBS or 1000 IRU/ml of either murine IFNa
deficient mice did not. In similar experiments, peritonealor murine IFNg for either 2 hr (for IRF1 induction) or 6 hr (for induction
macrophages (Figure 5, middle) or bone marrow±of the other transcripts), and RNA was prepared as outlined in Exper-
derived macrophages (data not shown) obtained fromimental Procedures. Northern blot analyses were conducted using
15 mg of RNA per lane and employing as probes 32P-labeled full- wild-type mice displayed robust induction of MHC class
length cDNAs that encoded murine IRF1, murine GBP1, human class II proteins following a 72 hr exposure to IFNg. In contrast,
II transactivator (CIITA), murine complement protein C3, or actin. cells from STAT1-deficient mice did not express in-
creased levels of MHC class II following exposure to
IFNg. Interestingly, a small percentageof peritonealcells
Lack of IFNa- and IFNg-Induced Gene (15%) and the majority of splenic B cells derived from
Activation in Cells Derived from STAT1-deficient mice were found to express MHC class
STAT1-Deficient Mice II proteins constitutively at levels comparable with those
IFNa and IFNg are known to induce the transcriptional found in wild-type littermates. However, neither the per-
activation of a variety of genes in many different cell centage nor the staining intensity of the class II±positive
types (Kerr and Stark, 1991; Darnell et al., 1994). For macrophages was altered following IFNg treatment of
many of these genes, activation is thought to involve STAT1-deficient cells. Thus, STAT1-deficient mice dis-
the participation of STAT1. Therefore we compared the play a selective blockade only in the component of MHC
ability of either IFNa or IFNg to induce gene transcription class II expression that is IFNg inducible. Finally,
in bone marrow±derived macrophages generated from whereas bone marrow macrophages from wild-type
wild-type or STAT1-deficient mice. In agreement with mice expressed the immune costimulator molecule B7-2
the findings of others (Fujita et al., 1989), we observed following 72 hr of incubation with IFNg, cells from
that cells from wild-type mice expressed low levels of STAT1-deficient mice were unresponsive (Figure 5,
mRNA for interferon regulatory factor 1 (IRF1) that was bottom).
enhanced 50-fold following treatment of the cells for 2
hr with either IFNa or IFNg (Figure 4, top left panel). The Lack of IFN-Induced Antimicrobial and
same basal level of IRF1 mRNA expression was also Antiviral Activities in Cells Derived
observed in cells derived from STAT1-deficient mice from STAT1-Deficient Mice
(Figure 4, top right panel). However, in these cells IRF1 Wild-type and STAT1-deficient cells were also com-
transcript levels were not altered following treatment pared for the ability to generate IFN-dependent re-
with either IFNa or IFNg. IFN unresponsiveness was not sponses important for promoting nonspecific host resis-
tance to microbial pathogens and viruses. One suchcorrected by use of higher concentrations of IFNa or
Cell
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Figure 6. Lack of IFN-Dependent iNOS Induction and Antiviral Re-
sponse in Cells from STAT1-Deficient Mice
(Top) Resident peritoneal macrophages derived from wild-type (WT)
or STAT1-deficient mice (Stat1 Def) were harvested by peritoneal
lavage and plated at 2 3 105 cells per well in 96-well tissue culture
plates. Cells were incubated for 48 hr with combinations of murine
IFNg (1000 IRU/ml) and LPS (5 ng/ml) or human IFNaA/D (1000 IRU/
ml) and LPS (5 ng/ml), and NO levels in the supernatant were quanti-Figure 5. Lack of IFN-Dependent Induction of Immunoregulatory
tated using the Greiss reagent.Proteins on Cells from STAT1-Deficient Mice
(Bottom) Immortalized MKFs from wild-type or STAT1-deficient
(Top) Peripheral blood derived from wild-type or STAT1-deficient mice were plated at 3.6 3 104 cells per well in 96-well tissue culture
mice was treated with 1000 IRU/ml of either murine IFNg or human plates and incubated with serial dilutions of either murine IFNg or
IFNaA/D (a species-nonspecific form of human IFNa) for 72 hr, and murine IFNa. After 24 hr, plates were washed and cell cultures were
cell surface expression of MHC class I proteins was then determined challenged with VSV. Cell viability was quantitated 24 hr later by
by flow cytometry. vital dye uptake and spectroscopy at 540 nm.
(Middle) Wild-type or STAT1-deficient mice were injected intraperi-
toneally with either saline or 5 3 104 IRU of murine IFNg on days 1
and 2 and then harvested on day 4 by peritoneal lavage. Cells
accumulation of nitrite in the medium after 48 hr of cul-were stained for MHC class II protein expression, and fluorescence
intensity was quantitated by flow cytometry. ture. In contrast, no nitrite was detected in culture super-
(Bottom) Bone marrow macrophages derived from wild-type or natants of STAT1-deficient macrophages treated with
STAT1-deficient mice were incubated for 72 hr with PBS or 1000 LPS and either IFNg or IFNa.
IRU/ml of murine IFNg, stained for expression of B7-2, and analyzed
We also assessed whether IFNa or IFNg could induceby flow cytometry.
antiviral activity in STAT1-deficient cells (Figure 6, bot-
tom). For these experiments, we monitored the ability
of IFNa or IFNg to protect immortalized wild-type or
response is the induction of the enzyme inducible nitric STAT1-deficient MKFs from the cytopathic effects of
oxide synthase (iNOS) that is responsible for high level vesicular stomatitis virus (VSV). IFNa or IFNg protected
production of nitric oxide (NO), a toxic gas that plays a wild-type immortalized fibroblasts from VSV infection in
critical effector role in the destruction of intracellular a dose-dependent manner. In contrast, no protective
pathogens in mice (Nathan and Xie, 1994). This enzyme response was induced in STAT1-deficient cells by either
is induced in cells by a combination of two stimuli: either form of IFN, even when the proteins were added at a
IFNa or IFNg or any one of a variety of substances 10,000-fold excess over the amount required to induce
(such as lipopolysaccharide [LPS], tumor necrosis factor antiviral activity in wild-type cells.
[TNF], or IL-1) that utilize the c-Rel family of proteins for
signaling. For these experiments, peritoneal macro- STAT1-Deficient Mice Are Exquisitely
phages derived from wild-type or STAT1-deficient mice Sensitive to Infection by Microbial
were exposed to combinations of LPS and either IFNa Pathogens and Viruses
or IFNg, and iNOS induction was quantitated by measur- To establish unequivocally the physiologic relevance of
ing the generation of the stable NO catabolic product the observations described thus far, we examined the
nitrite (Figure 6, top). Treatment of wild-type cells with ability of STAT1-deficient mice to withstand in vivo chal-
lenge with either a microbial pathogen or a virus. Theeither IFNg plus LPS or IFNa plus LPS led to significant
Selective IFN Unresponsiveness in STAT1-Deficient Mice
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Figure 7. STAT1-Deficient Mice Show Defective Responses to L.
monocytogenes Infection
Five member groups of wild-type mice, wild-type mice treated with
300 mg of neutralizing MAb specific for murine IFNg (H22), mice
heterozygousfor the disrupted Stat1 allele (heterozygote), or STAT1-
deficient mice were injected intraperitoneally with 1.5 3 104 cfu of
live Listeria per mouse, and viability was monitored over a 14 day
period.
first set of experiments compared the ability of wild-
type and STAT1-deficient mice to resist infection by
a sublethal dose of the intracellular bacterium Listeria
monocytogenes. Anti-Listeria responses have been
shown to be dependent on the production and action
of endogenously produced IFNg. Previous experiments
had established that normal mice treated with neutraliz-
ing monoclonal antibody (MAb) to IFNg (Buchmeier and Figure 8. Inability of STAT1-Deficient Mice to Resist VSV Infection
Schreiber, 1985), or mice with targeted disruption of the (A) Five member groups of wild-type mice, mice heterozygous for
the disrupted Stat1 allele, heterozygote mice treated with 250 mggenes for either IFNg (Dalton et al., 1993) or the IFNg
of H22, or STAT1-deficient mice were injected intravenously withreceptor a chain (Huang et al., 1993), die when infected
2 3 106 pfu of VSV per mouse. Viability was monitored daily over awith a dose of Listeria that is sublethal in normal mice.
3 week period.
When injected with 1.5 3 104 cfu of Listeria, wild-type (B) Five member groupsof STAT1-deficient mice were injected intra-
mice or mice heterozygous for the disrupted Stat1 allele venously with different doses of VSV, ranging from 2 3 106 pfu to
were able to mount a curative anti-Listeria response and 2 x 101 pfu per mouse. As a control, a five member group of wild-type
mice was injected with 2 3 106 pfu of VSV. Viability was monitored assurvived the infection (Figure 7). In contrast, STAT1-
in (A).deficient mice were highly sensitive to the bacteria and
died as a result of the infection. The kinetics of death
of the infected STAT1-deficient mice were similar to challenged with 2 3 106 pfu of virus survived the infec-
tion. In contrast, STAT1-deficient mice were severelythose displayed by anti-IFNg-treated wild-type mice in-
fected with Listeria. compromised in their ability to resolve infection with
VSV and died following challenge with as few as 200We also monitored the ability of STAT1-deficient mice
to resist infection by a sublethal dose of VSV. Work by pfu of virus.
Taken together, these results document that STAT1MuÈ ller et al. (1994) has shown that mice lacking function-
ally active IFNg receptorsare able to resist VSV infection, deficiency results in a generalized ablation of IFNa and
IFNg responsiveness both in vitro or in vivo and thuswhile mice lacking functionally active IFNa receptors
are highly susceptible to VSV infection. Thus, this model demonstrate that STAT1 plays an obligate role in medi-
ating many, if not all, IFN-dependent biologic responses.measures IFNa-mediated antiviral responses in vivo.
Wild-type mice, mice heterozygous for the disrupted
Stat1 allele, and heterozygote mice treated with neu- STAT1-Deficient Mice Do Not Display
Defects in Responsiveness totralizing MAb to murine IFNg survived challenge with
2 3 106 pfu of VSV (Figure 8A). In contrast, STAT1- Other Cytokine Ligands
Having established an obligate role for STAT1 in promot-deficient mice succumbed rapidly to injection with 2 3
106 pfu of VSV, with all mice in the group dying by ing IFN-dependent cellular responses, we then as-
sessed whether STAT1 was also required for effecting5 days.
To explore the extent of host response defects in the biologic responses to at least some of the other cyto-
kines that have been reported to activate STAT1 in vitro.STAT1-deficient mice, we infected groups of mice with
different doses of live VSV and monitored lethality (Fig- This issue was examined by comparing biologic re-
sponses induced in either wild-type or STAT1-deficienture 8B). As in the previous experiment, wild-type mice
Cell
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cells with three representative members of this cytokine
group, namely growth hormone (GH), EGF, and IL-10,
all three of which have been reported to activate STAT1
and STAT3 (Gronowski et al., 1995; Fu and Zhang, 1993;
Finbloom and Winestock, 1995).
STAT1-deficient mice showed normal developmental
weight gain, indicating that they display normal respon-
siveness to endogenously produced GH (Figure 9, top
left panel). Moreover, STAT1-deficient mice responded
to administration of exogenous GH in a manner that was
indistinguishable from that displayed by wild-type mice.
Following twice daily treatment for 17 days with 100 mg
of recombinant rat GH per treatment, wild-type mice
gained 16.4% of body weight compared with a matched
group that received vehicle only, and STAT1-deficient
mice gained 15.6% body weight compared with control
(Figure 9, top right panel).
To compare EGF responses in wild-type and STAT1-
deficient mice, we treated groups of two mice each
either with PBS or 200 mg/kg of EGF and quantitated
induction of c-fos, JunB, and Zif268 genes 30 min later
in liver and stomach by Northern blot analysis (Figure
9, middle). No significant differences were noted in EGF-
induced gene expression in tissues derived from either
STAT1-sufficient or STAT1-deficient mice.
Finally, macrophages derived from wild-type and
STAT1-deficient mice displayed identical responsiveness
to IL-10, as shown by the ability of IL-10 to inhibit 83.8%
and 75.4% of LPS-stimulated TNF production in the two
cell types, respectively (Figure 9, bottom). Interestingly,
EMSAs performed on IL-10-treated macrophages re-
vealed that IL-10 induced the formation in wild-type
macrophages of three DNA-binding complexes con-
sisting of a STAT3 homodimer, a STAT1/STAT3 hetero-
dimer, and a STAT1 homodimer, while IL-10 induced
formation of only the STAT3 homodimer in STAT1-defi-
cient cells (data not shown). This result indicates that
IL-10 responses in cells (and perhaps GH and EGF re-
sponses as well) may be mediated predominantly by
Figure 9. STAT1-Deficient Mice Show Normal Responses to GH,activated STAT3 and that STAT1 activation may repre-
EGF, and IL-10sent a by-product of STAT3 activation with no obligate
(Top) STAT1-deficient mice display normal constitutive weight gainfunctional consequence.
and are the same size as wild-type controls (left). Shown are repre-
Thus, although STAT1 plays an obligatory role in pro- sentative mice. Adult STAT1-deficient mice also display an identical
moting a wide variety of cellular responses induced by increase in body weight compared with wild-type controls following
both type I and type II interferons, an obligate role in a 17 day course of treatment with recombinant rat GH. Groups of
four mice (two males and two females) that had achieved a stablemediating biologic responses by other cytokines cannot
body weight were injected subcutaneously twice daily with eitherbe demonstrated.
100 mg per treatment of GH or diluent (right). Error bars represent
standard deviation.
(Middle) Normal EGF responsiveness in tissues from STAT1-defi-Discussion cient mice. Groups of two wild-type or STAT1-deficient mice were
injected intraperitoneally with either PBS or 200 mg/kg of EGF and
Previous work by others suggested that STAT1 plays then sacrificed at 30 min to obtain liver, stomach, and intestine for
isolation of RNA. Activation of EGF-inducible genes was quantitatedan important role in mediating transcriptional activation
by Northern blot analysis using 32P-labeled cDNA probes for threeof certain IFN-inducible genes in specific cell types in
EGF-inducible genes, c-fos, JunB, and Zif268. Shown here are thevitro (Darnell et al., 1994; Schindler and Darnell, 1995);
blots obtained from stomach.
the data presented in this report establish the physio- (Bottom) IL-10 induces normal suppression of LPS-mediated TNF
logic importance of STAT1 in cytokine signaling. Our production in peritoneal macrophages derived from STAT1-deficient
study clearly shows that cells and tissues of STAT1- mice. We treated 1 3 105 resident peritoneal macrophages derived
from wild-type or STAT1-deficient mice with PBS or 50 ng/ml recom-deficient mice display a generalized state of unrespon-
binant murine IL-10 and then exposed them to 50 ng/ml LPS. Aftersiveness to either IFNa or IFNg when tested either under
24 hr, TNFa accumulation in the culture media was determined bywell-controlled in vitro conditions or under physiologic
enzyme-linked immunosorbent assay (ELISA).
in vivo conditions in intact mice. Since this comprehen-
sive analysis of IFN signaling in STAT1-deficient mice
Selective IFN Unresponsiveness in STAT1-Deficient Mice
439
failed to identify alternative pathways of IFN signaling, expression can also be regulated by other cytokines,
we conclude that STAT1 plays an obligate role in pro- such as IL-6, granulocyte/macrophage-CSF (GM-CSF),
moting most, if not all, IFN-dependent biologic re- and IL-4 (Harroch et al., 1994), and thus the phenotype
sponses. of the STAT1-deficient mice does not entirely overlap
In contrast, the STAT1-deficient mice displayed no that observed in individuals with true genetic deficien-
obvious defects in responsiveness to any other cyto- cies of IRF1 and CIITA. Specifically, STAT1-deficient
kine. This result was unexpected, since previous reports mice do not display the CD81 T cell defects observed
showed that a variety of noninterferon agonists such as in the IRF1 knockout mice, and they produce the appro-
IL-6, IL-10, GH, EGF, PDGF, or thrombopoietin were priate cell subpopulations that express MHC class II
able to activate STAT1 to express DNA binding activity under basal conditions. This result indicates that ex-
when tested in vitro. However, STAT1-deficient mice pression of these two transactivators can also be ef-
did not display developmental or functional defects that fected by other mediators in addition to the interferons.
might be expected to accompany loss of respon- Nevertheless, our results document that the interferon
siveness to these cytokines (as determined in some signaling pathway, including STAT1, is the predominant
cases by the use of specific knockout mice, i.e., chronic pathway that leads to the physiologic induction of these
inflammatory disease in the IL-10 knockout mice [KuÈ hn genes during the development of host defense re-
et al., 1993] and lethality in the EGF receptor knockout sponses.
mice [Miettinnen et al., 1995] and gp130 knockout mice The results presented here lend significant support
[Yoshida et al., 1995]) nor did they show any abnormali- to a model in which particular STAT proteins play a
ties in responsiveness to GH, EGF, or IL-10 when for- dedicated role in mediating signaling by defined sub-
mally tested either in vivo or in vitro. This observation groups of cytokine receptors. Although this concept was
thus supports the conclusion that the essential physio- supported by the observation that certain STAT proteins
logic function of STAT1 is limited to effecting IFN-medi- appear to function in an exclusive manner with particular
ated cellular responses. cytokine receptors (e.g., STAT2 for IFNa [Fu et al., 1992],
The biologic relevance of STAT1 activation by nonin- STAT4 for IL-12 [Jacobson et al., 1995], and STAT6 for
terferon agonists remains uncertain. At this time we can- IL-4 [Hou et al., 1994]), it was in the past weakened
not rule out the possibility that activated STAT1 homodi- by the apparent wide utilization of STAT1, STAT3, and
mers or STAT1-containing heterodimers that may form
STAT5 by a variety of cytokine receptors, which often
following engagement of a cytokine receptor by a nonin-
induced nonoverlapping and sometimes opposite bio-
terferon ligand might contribute to the total magnitude
logic responses (Schindler and Darnell, 1995). The docu-
of the biologic response induced. However, it is clear
mentation presented in this report now permits us to
from our study that such a contribution would be of a
place STAT1 into the same group as STAT2 with regard
relatively minor quantitative nature only. It is also possi-
to its physiologic role in promoting IFN-dependent re-ble that at least some of the in vitro observations con-
sponses. This placement thereby leaves STAT3 andcerning STAT1 activation by noninterferon cytokines
STAT5 in a group that is consistently associated withmay be the result of the use of cell lines that have been
cytokine receptors (such as IL-2 receptor, the IL-3/GM-chosen or engineered to contain nonphysiologic levels
CSF receptor family, the IL-6 receptor family, andof receptors or may reflect the nonphysiologic oversti-
erythropoietin) that promote cellular proliferation andmulation of a cytokine receptor with vast excesses of
differentiation responses. It is likely that, within eachcytokine agonists.
restricted subgroup of STAT proteins, the specific pat-The generation of STAT1-deficient mice has allowed
tern of cytokine-induced genes will be the result of aus to establish the functional position of this transcrip-
combinatorial heterogeneity that occurs between thetion factor relative to two other transactivators, IRF1
particular subgroup members that are specifically re-and CIITA, that are known to play critical roles in driving
cruited by the activated cytokine receptor.a variety of cytokine-dependent responses (Harada et
al., 1989; Glimcher and Kara, 1992). By comparing the
Experimental Proceduresfunctional defects exhibited by the STAT1-deficient
mice with those displayed by IRF1-deficient mice (Mat-
Cytokines, Reagents, and General Protocolssuyama et al., 1993; Reis et al., 1994) and CIITA-deficient
Purified recombinant cytokines were obtained from the followinghumans (Steimle et al., 1993), we can now place Stat1
sources: murine IFNg and rat GH were obtained from Genentechupstream from these other two transactivators. Activa-
(South San Francisco, CA); murine IFNa was provided by Drs. Sat-
tion of the genes for both IRF1 and CIITA by IFN requires want Narula and T. L. Nagabhushan of the Schering±Plough Re-
STAT1, since neither gene is induced in IFN-treated cells search Institute (Kenilworth, NJ); human IFNaA/D was a gift from
of STAT1-deficient mice. Moreover, the response de- Drs. Gianni Garotta and Michael Brunda Hoffmann-LaRoche (Basel,
fects to IFN observed in our mice encompass many of Switzerland and Nutley, NJ); human EGF was prepared as described
previously (DuBois et al., 1995), and murine IL-10 was producedthe defects observed in mice or individuals with genetic
according to published procedures (Weber-Nordt et al., 1994). Alldeficiencies of either IRF1 (such as the failure to induce
tissue culture media and medium components used in this studyiNOS or MHC class I proteins) or CIITA (such as the
were free of endotoxin as tested by Limulus amebocyte lysate assayfailure to induce MHC class II proteins), respectively.
(BioWhittaker, Walkersville, MD). All experiments presented were
These observations suggest that STAT1 functions as performed at least three times.
the link between the ligated IFN receptor and the down-
stream branch points in the signaling pathway that are Targeting Vector
directly responsible for channeling the pleiotropic ac- Genomic clones containing portions of the murine Stat1 gene were
isolated from a lFix II murine 129/Sv genomic library (purchasedtions of the interferons. However, IRF1 and CIITA gene
Cell
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from Stratagene, LaJolla, CA) by screening the library using the full- mg of expression plasmids encoding wild-type or mutant murine
STAT1 using the calcium phosphate method (Farrar et al., 1991).length human Stat1 cDNA as a probe. Two overlapping phage clones
(clones 2 and 6) containing 59 sequences of the murine Stat1 gene The STAT1-deficient U3A cell line was provided by Dr. George
Stark of the Research Institute of the Cleveland Clinic (Cleveland,were identified in addition to 12 other clones that encoded the
remaining 39 regions of the Stat1 locus. To generate the Stat1- OH) and was cultured as described previously (McKendry et al.,
1991). U3A cells were stably transfected with plasmids encodingtargeting vector pNT-91, an 8 kb BamHI±SauI fragment of clone
6 containing exon 4 was inserted into the targeting vector wild-type or abnormal murine STAT1 using the calcium phosphate
method, selected on G418 (0.4 mg/ml), and cloned by limitingpTK.NEO.UMS (Reis et al., 1994) such that its 39 end was adjacent
to the polyoma enhancer promoter±driven herpes simplex virus thy- dilution.
midine kinase gene. The 59 end of thetargeting construct was gener-
ated from Stat1 genomic clone number 2 and contained a 900 bp
EMSANotI±SauI fragment that included intronic sequence just upstream
We stimulated 5 3 106 bone marrow macrophages in 1 ml of PBS,from the ATG start codon in exon 1 (Figure 1).
10% FCS with 10,000 U/ml of murine IFNg for 7 min at 378C and
analyzed them by EMSA as described previously (Greenlund et al.,
Transfection of Embryonic Stem Cells 1994) using an 18 bp oligonucleotide probe that contained the g
and Generation of STAT1-Deficient Mice response region of the FcgRI gene.
The GS-1 embryonic stem cell line was cultured essentially as de-
scribed (Huang et al., 1993). Embryonic stem cells were electropor-
Activation of IFN-Inducible Genesated with 20 mg of NotI-linearized pNT-91 per 1 3 107 cells and
and Northern Blot Analysisgrown under double selection as described previously (MuÈ ller et al.,
Bone marrow macrophages, plated at 2 3 107 cells per 12 ml of1994). We analyzed 96 colonies for homologous recombination by
D-10 in 10 cm petri dishes, were treated with medium, recombinantPCR using a sequence derived from probe A (Figure 1): 59 sequence,
murine IFNg (1000 IRU/ml), or recombinant murine IFNa (1000 IRU/CTCAGGCTGACCTTGGAACTTGTG; 39 sequence was derived from
ml) for 2, 6, or 24 hr. RNA was isolated from the cells and analyzed27 bp of the neo gene sequence (ATTCGCAGCGCATCGCCTTCTAT
by Northern blotting using standard procedures (Sambrook et al.,CGCC). Three positive clones (F11, D8, and C8) were identified by
1989).the presence of a 1.7 kb PCR product and were microinjected into
For in vivo studies, mice were injected intraperitoneally with PBSblastocysts to generate STAT1-deficient mice.
or different cytokines and then sacrificed after different periods of
time. Organs were washed in PBS and homogenized in 2±4 ml of
STAT1 Immunoprecipitation and Western Blotting RNAzol B solution (TEL-TEST, Friendsville, TX), and the lysates were
Spleen, thymus, and cultured bone marrow macrophages were cleared by centrifugation at 15,000 rpm for 10 min at 48C. RNA was
washed in PBS and resuspended to 2.5 3 107 cells per milliliter in isolated from the aqueous phase and analyzed as described above.
lysis buffer consisting of 50 mM Tris (pH 7.5), 150 mM NaCl, 1% The following cDNA probes were used in these studies: murine
Triton X-100, 0.5% deoxycholic acid, 0.1% SDS, 1 mM PMSF, 1 mM IRF1, GBP1, and C3 cDNAs were provided by Dr. Tadatsugu Tani-
sodium orthovanadate, 10 mM NaF, 10 mg/ml leupeptin, 10 mg/ml guchi (University of Tokyo, Japan), Dr. Donna Paulnock (University
aprotinin. Livers were homogenized in 2 ml of lysis buffer using an of Wisconsin, Madison), and Drs. Gerard Garnier and Harvey Colten
Ultra-Turrax tissue homogenizer (Tekmar, Cincinnati, OH). Lysates (Washington University Medical School, St. Louis, MO), respectively.
were cleared by centrifugation at 10,000 rpm for 10 min at 48C. The human CIITA and rat c-fos cDNAs were provided by Dr. Laurie
Proteins were immunoprecipitated using the STAT1 carboxyl termi- Glimcher (Harvard Medical School, Boston, MA) and Dr. Jeffrey
nus±specific SC-111 MAb (Santa Cruz Biotechnologies, Santa Cruz, Milbrandt (Washington University Medical School), respectively. The
CA) and protein G±Sepharose (Pharmacia, Piscataway, NJ), as pre- cDNA probes for Zif268, Nup475, and JunB were used as described
viously described (Greenlund et al., 1995). SDS±PAGE and Western elsewhere (DuBois et al., 1995). Probes were labeled using the ran-
blotting were performed using 8% polyacrylamide gels as described dom primer kit of Amersham.
previously (Greenlund et al., 1994). Membranes were probed with
either biotinylated ATO-1D6 or ATO-2F5 MAbs specific for the
Induction of Cell Surface ImmunoregulatorySTAT1 SH2 domain produced in our laboratory (Greenlund et al.,
Proteins and FACS Analysis1995) and HRP-conjugated streptavidin (Zymed, South San Fran-
Peripheral blood was harvested from mice and cultured for 72 hr incisco, CA) or with rabbit antisera specific for the STAT1 amino or
vitro in the presence of PBS or 1000 IRU/ml of either IFNa or IFNg.carboxyl termini (gifts from Dr. ChristianSchindler, Columbia Univer-
MHC class I expression on T cells in the cultures was assessed bysity and Dr. James Darnell, Rockefeller University) and HRP-conju-
FACS as described elsewhere (Dighe et al., 1995) by staining withgated goat anti-rabbit IgG (Bio-Rad, Hercules, CA). Blots were then
FITC anti±murine CD3 antibody and biotinylated anti±murine H-2bdeveloped using the ECL reagent (Amersham, Arlington Heights,
(Pharmingen, San Diego, CA), followed by streptavidin±PE (Chro-IL). Densitometry was performed using a Bio-Rad 620 video densi-
moprobe, Mt. View, CA). The same protocol was used to quantitatetometer.
MHC class I induction in IFN-treated MKF cells andU3A cells, except
that for the latter human cell line a biotinylated anti±human MHC
Cell Culture and Transfection class I MAb was used. Bone marrow or peritoneal macrophages
Bone marrow±derived macrophages were generated as previously were cultured for 72 hr with PBS or 1000 IRU/ml of either IFNa or
described (Celada et al., 1984) with some modifications. We cultured IFNg and stained for expression of MHC class II using biotinylated
1 3 107 bone marrow cells in 40 ml of Dulbecco's modified Eagle's MAb specific for murine I-Ab/d (provided by Dr. Skip Virgin of the
medium containing 10% heat-inactivated FCS, 5% heat-inactivated Washington University Medical School). As a control, cells were
horse serum, 4 mM L-glutamine, 1 mM sodium pyruvate, 50 U/ml pretreated with excess nonbiotinylated anti-I-Ab/d or were stained
of penicillin, 50 mg/ml streptomycin, and 1% nonessential amino with an irrelevant anti±MHC class II reagent (anti-I-Ek). Similar tech-
acids (D-10) supplemented with 25% (v/v) L cell±conditioned me- niques were used to assess expression of B7-2 on IFNg-treated
dium in nontissue culture±treated 150 mm petri dishes for 7 days. macrophages using a B7-2-specific MAb purchased from Phar-
The resulting bone marrow±derived macrophages were harvested mingen.
with cold endotoxin-free sterile PBS, washed, and then replated at
2 3 107 cells per 100 mm dish in D-10 and cultured for an additional
4±6 days. Cells were harvested by gentle scraping in cold PBS prior NO Induction
Resident peritoneal macrophages (2 3 105 per well) were stimulatedto use.
Third passage primary MKFs were immortalized by transfection in triplicate in 96-well plates with LPS (5 ng/ml) and 1000 IRU/ml
of murine IFNg or human IFNaA/D. After a 48 hr culture at 378C,with the pPSVE1-B1a plasmid encoding the polyoma virus large T
antigen as described (Muller et al., 1984). To express STAT1 in supernatants were harvested, and the level of nitrite was determined
as described previously (Farrar et al., 1992).immortalized MKFs, we transiently transfected 1 3 106 cells with 20
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Antiviral Activity Assay DuBois, R.N., Bishop, P., Graves-Deal, R., and Coffey, R.J. (1995).
TGFa regulation of two zinc finger containing immediate early re-The ability of immortalized MKFs to resist VSV infection was deter-
mined using a cytopathic effect assay performed essentially as de- sponse genes in the intestine. Cell Growth Differ. 6, 523±529.
scribed previously (Leinikki et al., 1987). In this assay, immortalized Farrar, M.A., Fernandez-Luna, J.,and Schreiber, R.D. (1991). Identifi-
MKFs were seeded in triplicate into 96-well tissue culture plates at cation of two regions within the cytoplasmic domain of the human
a density of 8 3 104 cells per well and incubated with serial dilutions interferon-g receptor required for function. J. Biol. Chem. 266,
of IFNa or IFNg. After 24 hr, plates were washed, and the cells were 19626±19635.
exposed to VSV. Cell viability was determined 30 hr later by crystal
Farrar, M.A., Campbell, J.D., and Schreiber, R.D. (1992). Identifica-violet staining and quantitated by spectroscopy at 540 nm.
tion of a functionally important sequence motif in the carboxy termi-
nus of the interferon-g receptor. Proc. Natl. Acad. Sci. USA 89,
In Vivo Responses to Bacteria and Virus
11706±11710.
Mice were injected intraperitoneally with live L. monocytogenes
Finbloom, D.S., and Winestock, K.D. (1995). IL-10 induces the tyro-(1.5 3 104 cfu per mouse) as described previously (Buchmeier and
sine phosphorylation of tyk2 and jak1 and the differential assemblySchreiber, 1985). Animals were monitored twice daily for survival
of Stat1a and Stat3 complexes in human T cells and monocytes. J.over a period of 2 weeks. Some animals were treated 6 hr prior to
Immunol. 155, 1079±1090.infection with 300 mg of H22, a neutralizing MAb specific for murine
IFNg (Schreiber et al., 1985). Fu, X.-Y., and Zhang, J.-J. (1993). Transcription factor p91 interacts
Mice were injected intravenously with different doses of VSV (Indi- with the epidermal growth factor receptor and mediates activation
ana strain) in a volume of 0.3 ml as previously described (MuÈ ller et of the c-fos gene promoter. Cell 74, 1135±1145.
al., 1994). Animals were monitored daily for survival over a 3 week Fu, X.-Y., Schindler, C., Improta, T., Aebersold, R., and Darnell,
period. Some mice were pretreated with 250 mg of the H22 MAb 1 J.E., Jr. (1992). The proteins of ISGF-3, the interferon a-induced
day prior to infection. transcriptional activator, define a gene family involved in signal
transduction. Proc. Natl. Acad. Sci. USA 89, 7840±7843.
IL-10 Bioassay
Fujita, T., Reis, L.F., Watanabe, N., Kimura, Y., Taniguchi, T., andThe ability of purified recombinant murine IL-10 to inhibit LPS-
Vilcek, J. (1989). Induction of the transcription factor IRF-1 anddependent TNFa production in resident peritoneal macrophages
interferon-b mRNAs by cytokines and activators of second-messen-was determined as described previously (Weber-Nordt et al., 1994).
ger pathways. Proc. Natl. Acad. Sci. USA 86, 9936±9940.
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